Synthesis and biological evaluation of purpurealidin E-derived marine sponge metabolites: Aplysamine-2, Aplyzanzine A, and Suberedamines A and B

Journal of Natural Products

Volumn 75, Issue 6, 2012, Pages 1090-1101

  Kottakota, Suresh K ^a   Evangelopoulos, Dimitrios ^b   Alnimr, Amani ^b   Bhakta, Sanjib ^b   McHugh, Timothy D ^b   Gray, Mark ^a   Groundwater, Paul W ^c   Marrs, Emma C L ^d   Perry, John D ^d   Spilling, Christopher D ^e   Harburn, J Jonathan ^a  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d FREEMAN HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APLYSAMINE 2; APLYZANZINE A; ISO ANOMOIAN A; NATURAL PRODUCT; PURPUREALIDIN E; SUBEREDAMINE A; SUBEREDAMINE B; UNCLASSIFIED DRUG; ALKALOID; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; APLYSAMINE-2; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; TYROSINE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REACTION ANALYSIS; SPONGE (PORIFERA); STRUCTURE ANALYSIS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; MARINE BIOLOGY; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

ANOMOIA; BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

4-BUTYROLACTONE; ALKALOIDS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; MARINE BIOLOGY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PORIFERA; TYROSINE;

EID: 84866458768     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np300102z     Document Type: Article

References (34)

1. For recent reviews see: (a) Peng, J.; Li; J.; Hamann, M. T. The Alkaloids 2005, 61, 59-262.
2. (b) Laport, M. S.; Santos, O. C. S.; Muircy, G. Curr. Pharm. Biotechnol. 2009, 10, 86-105.
3. (a) Thoms, C.; Schupp, P. J. J. Chem Ecol. 2008, 34, 1242-1252.
4. (b) Thoms, C.; Ebel, R.; Proksch, P. J. Chem. Ecol. 2006, 32, 97-123, and references therein.
5. (a) Quiñoà, E.; Crews, P. Tetrahedron Lett. 1987, 28, 3229-3232.
6. (b) Arabshahi, L.; Schmitz, F. J. Org. Chem. 1987, 52, 3584-3586.
7. Nicholas, G. M.; Eckman, L. L.; Ray, S.; Hughes, R. O.; Pfefferkorn, J. A.; Barluenga, S.; Nicolaou, K. C.; Bewley, C. A. Bioorg. Med. Chem. Lett. 2002, 12, 2487-2490.
8. (a) Nicholas, G. M.; Eckman, L. L.; Newton, G. L.; Fahey, R. C.; Ray, S.; Bewley, C. A. Bioorg. Med. Chem. 2003, 11, 601-608.
9. (b) Mahadevan, J.; Nicholas, G. M.; Bewley, C. A. J. Org. Chem. 2003, 68, 3380-3386.
10. Pina, I. C.; Gautschi, J. T.; Wang, G.-Y.-S.; Sanders, M. L.; Schmitz, F. J.; France, D.; Cornell-Kennon, S.; Sambucetti, L. C.; Remiszewski, S. W.; Perez, L. B.; Bair, K. W.; Crews, P. J. Org. Chem. 2003, 68, 3866-3873.
11. Kim, D.; Lee, I. S.; Jung, J. H.; Lee, C. O.; Choi, S. U. Anticancer Res. 1999, 5B, 4085-4090.
12. Mora, F. D.; Jones, D. K.; Desai, P. V.; Patny, A.; Avery, M. A.; Feller, D. R.; Smillie, T.; Zhou, Y.-D.; Nagle, D. G. J. Nat. Prod. 2006, 69, 547-552.
13. McCulloch, M. W. B.; Coombs, G. S.; Banerjee, N.; Bugni, T. S.; Cannon, K. M.; Harper, M. K.; Veltri, C. A.; Virshup, D. M.; Ireland, C. M. Bioorg. Med. Chem. 2009, 17, 2189-2198.
14. Fischbach, M. A.; Walsh, C. T. Science 2009, 325, 1089-1093.
15. Rao, M. R.; Venkatesham, U.; Venkateswarlu, U. Indian J. Chem. 1999, 39B, 1301-1303.
16. Harburn, J. J.; Rath, N. P.; Spilling, C. D. J. Org. Chem. 2005, 70, 6398-6403.
17. Yoshida, M.; Yamaguchi, K. Chem. Pharm. Bull. 2008, 56, 1362-1363.
18. (a) Xynas, R.; Capon, R. J. Aust. J. Chem. 1989, 42, 1427-1433.
19. (b) Kernan, M. R.; Cambie, R. C. J. Nat. Prod. 1990, 53, 720-723.
20. (c) Evan, T.; Ilan, M.; Kashman, Y. J. Nat. Prod. 2001, 64, 226-227.
21. (d) Tsuda, M.; Sakuma, Y.; Kobayashi, J. J. Nat. Prod. 2001, 64, 980-982.
22. Kotoku, N.; Tsujits, H.; Hiramatsu, A.; Mori, C.; Koizumi, N.; Kobayashi, M. Tetrahedron 2005, 61, 7211-7218.
23. Boehlow, T. R.; Harburn, J. J.; Spilling, C. D. J. Org. Chem. 2001, 66, 3111-3118.
24. Brown, A. G.; Crimmin, M. J.; Edwards, P. D. J. Chem. Soc., Perkin Trans. 1 1992, 123-130.
25. Moore, M. L. Org. React. 1949, 5, 301-330.
26. Jung, M. E.; Roholf, J. C. J. Org. Chem. 1985, 50, 4909-4013.
27. Boger, D. L.; Yohannes, D. J. Org. Chem. 1988, 53, 487-489.
28. Personal communication with Professor Mark T. Hamann (University of Mississippi) confirmed the original correct structure assignment of anomoian A (ref 14b).
29. Andrews, J. M. Antimicrob. Chemother. 2001, 48 (Suppl 1), 5-16.
30. Evangelopoulos, D.; Bhakta, S. Methods Mol. Biol. 2010, 642, 193-201.
31. (a) Guzman, J. D.; Gupta, A.; Evangelopoulos, D.; Basavannacharya, C.; Pabon, L. C.; Plazas, E. A.; Munoz, D. R.; Delgado, W. A.; Cuca, L. E.; Ribon, L. E.; Gibbons, W.; Bhakta, S. J. Antimicrob. Chemother. 2010, 65, 2101-2107.
32. (b) Madikane, V. E.; Bhakta, S.; Russell, A. J.; Campbell, W. E.; Claridge, T. D.; Elisha, B. G.; Davies, S. G.; Smith, P.; Sim, E. Bioorg. Med. Chem. 2007, 15, 3579-3586.
33. (a) O'Donnell, G.; Poeschl, R.; Zimhony, O.; Gunaratnam, M.; Moreira, J. B.; Neidle, S.; Evangelopoulos, D.; Bhakta, S.; Malkinson, J. P.; Boshoff, H. I.; Lenaerts, A.; Gibbons, S. J. Nat. Prod. 2008, 72, 360-365.
34. (b) Westwood, I. M.; Bhakta, S.; Russell, A. J.; Fullam, E.; Anderton, M. C.; Akane Kawamura, A.; Mulvaney, A. W.; Vickers, R. J.; Bhowruth, V.; Besra, G. S.; Lalvani, A.; Davies, S. G.; Sim, E. Protein Cell 2010, 1, 82-95.